Comparison of standard versus accelerated corneal collagen cross-linking for keratoconus: 5-year outcomes from the Save Sight Keratoconus Registry Save Sight Registries Comparison of standard versus accelerated corneal collagen cross-linking for keratoconus: 5-year outcomes from the Save Sight Keratoconus Registry Read More »
Twenty-four-month real-life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in Caucasians Save Sight Registries Twenty-four-month real-life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in Caucasians Read More »
Evaluation of ocular neuropathic pain Save Sight Registries Evaluation of ocular neuropathic pain Read More »
Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience Save Sight Registries Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience Read More »
Mental Health Impact of Keratoconus: A Systematic Review Save Sight Registries Mental Health Impact of Keratoconus: A Systematic Review Read More »
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry Save Sight Registries Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry Read More »
Opportunities and challenges for clinical registries Save Sight Registries Opportunities and challenges for clinical registries Read More »
Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion Save Sight Registries Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion Read More »
Outcomes of switching from proactive to reactive treatment after developing advanced central neovascular age-related macular degeneration Save Sight Registries Outcomes of switching from proactive to reactive treatment after developing advanced central neovascular age-related macular degeneration Read More »
Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration Save Sight Registries Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration Read More »
Outcomes of Over 40,000 Eyes Treated for Diabetic Macula Edema in Routine Clinical Practice: A Systematic Review and Meta-analysis Save Sight Registries Outcomes of Over 40,000 Eyes Treated for Diabetic Macula Edema in Routine Clinical Practice: A Systematic Review and Meta-analysis Read More »
One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion Save Sight Registries One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion Read More »
